BCL2 and Parkinson disease: Beclin-1 serves as a molecular platform for initiating autophagosome formation, and its interaction with anti-apoptotic protein Bcl-2 or inflammasomes leads to autophagy dysfunction and promotes the onset of PD [409,410].